Blood endotoxin levels in impaired glucose tolerance and diabetes: prospective study
Not Applicable
- Conditions
- impaired glucose tolerance (IGT) and diabetes mellitus (DM)
- Registration Number
- JPRN-UMIN000030290
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Acute phase of infection 2)Digestive disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of blood endotoxin levels between at admission and discharge in treatment of diabetes.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link blood endotoxin levels to impaired glucose tolerance and diabetes mellitus in JPRN-UMIN000030290?
How does endotoxemia monitoring compare to traditional biomarkers in predicting diabetes progression in observational studies?
Which biomarkers correlate with blood endotoxin levels in patients with IGT or T2DM according to Tohoku University Hospital research?
What adverse metabolic outcomes are associated with elevated endotoxin in JPRN-UMIN000030290's observational cohort?
How might endotoxin-targeting therapies like prebiotics or antibiotics complement standard diabetes treatments for IGT populations?